-
-
-
-
-
-
-
Edwards Lifesciences Reports Third Quarter Results
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Hold Rating on Edwards Lifesciences (EW)
-
-
-
-
-
-
-
EW Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifescience Corporation (EW) Investors of Deadline and Encourages Investors with Losses to Contact the Firm
-
-
-
-
-
-
-
Edwards Lifesciences (EW) PT Lowered to $90 at Oppenheimer
-
-
-
-
-
-
-
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
-
-
-
-
-
-
-
Edwards Lifesciences Reports Third Quarter Results
-
-
-
-
-
-
-
Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

